PACS Group (NYSE:PACS) Earns Buy Rating from Analysts at Citigroup

Citigroup initiated coverage on shares of PACS Group (NYSE:PACS) in a research report report published on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $32.00 price target on the stock.

Several other research firms have also recently weighed in on PACS. Truist Financial initiated coverage on PACS Group in a research report on Monday. They issued a buy rating and a $32.00 price objective on the stock. Oppenheimer started coverage on shares of PACS Group in a report on Monday. They issued an outperform rating and a $31.00 price target on the stock. Finally, Royal Bank of Canada began coverage on PACS Group in a research note on Monday. They issued an outperform rating and a $30.00 target price on the stock. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of Buy and an average price target of $30.50.

PACS Group Stock Up 0.7 %

Shares of PACS stock opened at $24.85 on Monday. PACS Group has a 52-week low of $22.61 and a 52-week high of $25.72.

Insider Activity

In related news, CEO Jason Hulse Murray sold 1,607,142 shares of the company’s stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the sale, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.